PET/CT is best at imaging neuroendocrine tumor heart metastases

03/19/2010 | Doctor's Guide

A study aiming to determine the best imaging method for identifying neuroendocrine tumor metastases to the heart among patients with progressive tumors found that results of MRI and Ga-68 DOTA somatostatin-receptor PET/CT scans were consistent in approximately 91% of cases. The sensitivity of SMS-R PET/CT was 92%, higher than echocardiography's 57%, CT's 32% and FDG PET/CT's 12%, the study found.

View Full Article in:

Doctor's Guide

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX